Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6844.5000 -139.00 (-1.99%)
NSE Jul 10, 2025 15:57 PM
Volume: 183.7K
 

6844.50
-1.99%
Axis Direct
Q4 revenue declined 3% YoY in line with our estimate, while EBITDA adjusted for Rs 290 mn of forex loss at Rs 3.9 bn was 9% below our estimate. Adj. PAT declined 10% YoY at Rs 2.88 bn, 12% below our estimate.
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended